News Focus
News Focus
Followers 131
Posts 29747
Boards Moderated 0
Alias Born 12/21/2008

Re: Myth post# 99452

Sunday, 05/22/2016 4:33:46 PM

Sunday, May 22, 2016 4:33:46 PM

Post# of 105535
WRONG! IT SEEMS A PART WAS LEFT OUT!LMAO!
PharmaStem Therapeutics claims to hold certain patents relating to the storage, expansion and use of hematopoietic stem cells. In the past several years, PharmaStem has commenced suit against numerous companies involved in cord blood collection and preservation alleging infringement of its patents. In October 2003, after a jury trial, judgment was entered against certain of our competitors and in favor of PharmaStem in one of those suits. In February 2004, PharmaStem commenced suit against Cord Partners and certain of its competitors alleging infringement of its patents. Management of Cord Partners determined to settle, rather than to litigate, this matter. As a result, PharmaStem and Cord Partners entered into a Patent License Agreement in March 2004. Pursuant to since 2008, though the Company disputes that it owes any royalties to Pharmastem.As of September 30, 2015, the Company made a one-time adjustment of the previously held amount of approximately $226,000 in accounts payable and $120,000 in accrued expenses, to its income statement as a gain on a settlement payable of $346,269.  

Don’t ever wrestle with a pig. You’ll both get dirty, but the pig will enjoy it.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today